|
SFRS9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.698100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.142100E-02 |
| Normal-vs-Stage2 |
6.434900E-04 |
| Normal-vs-Stage3 |
1.020040E-03 |
| Normal-vs-Stage4 |
6.913800E-01 |
| Stage1-vs-Stage2 |
8.438500E-02 |
| Stage1-vs-Stage3 |
1.230250E-01 |
| Stage1-vs-Stage4 |
1.781850E-01 |
| Stage2-vs-Stage3 |
8.061200E-01 |
| Stage2-vs-Stage4 |
2.095800E-02 |
| Stage3-vs-Stage4 |
3.168400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.664480E-03 |
| Normal-vs-AfricanAmerican |
6.342400E-01 |
| Normal-vs-Asian |
8.932400E-01 |
| Caucasian-vs-AfricanAmerican |
7.410000E-02 |
| Caucasian-vs-Asian |
4.505600E-01 |
| AfricanAmerican-vs-Asian |
9.682400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.200500E-03 |
| Normal-vs-Female |
1.853820E-02 |
| Male-vs-Female |
6.391200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.493200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.162350E-02 |
| Normal-vs-Age(61-80Yrs) |
1.133630E-02 |
| Normal-vs-Age(81-100Yrs) |
1.021140E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.497400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.382200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.416200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.017000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.786100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.490000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.202200E-01 |
| Normal-vs-Grade 2 |
1.079810E-02 |
| Normal-vs-Grade 3 |
2.641700E-04 |
| Normal-vs-Grade 4 |
8.907400E-01 |
| Grade 1-vs-Grade 2 |
3.049400E-01 |
| Grade 1-vs-Grade 3 |
1.554420E-01 |
| Grade 1-vs-Grade 4 |
9.196200E-01 |
| Grade 2-vs-Grade 3 |
1.382760E-01 |
| Grade 2-vs-Grade 4 |
1.170250E-01 |
| Grade 3-vs-Grade 4 |
2.355900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.27979999930972E-08 |
| Normal-vs-ccB subtype |
2.149000E-01 |
| ccA subtype-vs-ccB subtype |
1.623500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.798300E-03 |
| Normal-vs-N1 |
3.518400E-01 |
| N0-vs-N1 |
1.782250E-02 |
|
|
